Open-access portal for a global antimicrobial resistance (AMR) surveillance programme

The Challenge

Since 2004, the client has been running a global antimicrobial resistance (AMR) surveillance programme — including the well-known ATLAS initiative. Over time, they amassed a staggering dataset: More than 900,000 clinical isolates, with in vitro susceptibility data across a broad spectrum of antibiotics and antifungals.

The goal? Make this data freely available to researchers, clinicians, and public health professionals around the world. No fees. No barriers. Just open access.

But enabling that at scale — with real-time search, deep filters, and bulletproof data quality — called for a custom digital solution.

Micron's Contribution

Our Approach & Impact

Micron built and maintains the open-access ATLAS platform, a web-based tool for exploring global AMR trends at scale.

Here’s what it delivers:

• 8+ million records across 900,000+ clinical isolates

• Searchable by:

• Pathogen

• Antimicrobial

• Demographic filters

• Phenotype and genotype

We receive raw data directly from the client’s central laboratory, then run it through rigorous quality control pipelines, using our proprietary closed testing systems.

Once verified, data is released through a secure public portal, where any registered user can explore, download, and report findings — free of charge. Users can instantly generate:

• MIC Distributions
• Susceptibility/Resistance rates
• Geographic heatmaps
• Custom demographic reports All outputs are downloadable, from global summaries down to individual isolate-level data.